Cardiovascular Intervention and Therapeutics最新文献_第6页

Current situation and overview of resorbable magnesium scaffolds: a perspective for overcoming the remaining issues of polymeric bioresorbable scaffold. 可吸收镁支架的研究现状及综述：从高分子生物可吸收支架的研究现状及发展展望。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-21 DOI: 10.1007/s12928-024-01070-w

Masaru Seguchi, Kenichi Sakakura, Yousuke Taniguchi, Hideo Fujita

{"title":"Current situation and overview of resorbable magnesium scaffolds: a perspective for overcoming the remaining issues of polymeric bioresorbable scaffold.","authors":"Masaru Seguchi, Kenichi Sakakura, Yousuke Taniguchi, Hideo Fujita","doi":"10.1007/s12928-024-01070-w","DOIUrl":"https://doi.org/10.1007/s12928-024-01070-w","url":null,"abstract":"Bioresorbable scaffolds (BRS) were developed as an innovative solution to overcome the limitations of metallic stents. While polymeric BRS initially demonstrated comparable clinical outcomes to drug-eluting stent (DES) in clinical trials, subsequent large-scale studies revealed that patients implanted with polymeric BRS experienced higher rates of scaffold thrombosis (ScT) and target lesion failure compared to those with metallic stents. Resorbable magnesium scaffolds (RMS) have emerged as a promising alternative owing to magnesium's natural degradability and favorable mechanical properties. Learning from the mechanism of polymeric BRS failure and through continuous improvements, recent clinical trials have shown promising clinical performance for RMS technology. However, comparative studies between RMS and DES have continued to highlight the remaining challenges with RMS, particularly in regard to late lumen loss. Recent advancements in third-generation RMS show improvements in strut thickness and homogeneous degradation, which enhances sustained structural integrity throughout the degradation process. Based on encouraging results from a first-in-human trial of the latest version of RMS, a randomized controlled trial has been initiated to compare the outcomes between metallic stents and the latest RMS, with patient enrollment already underway. This review aims to explore the limitations of polymeric BRS and provide an overview of the current developments and future potential of magnesium-based BRS.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease. 伴有或不伴有外周动脉疾病患者冠状动脉支架植入术后出血事件的临床结果

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-19 DOI: 10.1007/s12928-024-01073-7

Tineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, Carl E Schotborgh, Rutger L Anthonio, Ariel Roguin, Peter W Danse, Edouard Benit, Adel Aminian, Marc Hartmann, Gerard C M Linssen, Robert H Geelkerken, Carine J M Doggen, Clemens von Birgelen

{"title":"Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease.","authors":"Tineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, Carl E Schotborgh, Rutger L Anthonio, Ariel Roguin, Peter W Danse, Edouard Benit, Adel Aminian, Marc Hartmann, Gerard C M Linssen, Robert H Geelkerken, Carine J M Doggen, Clemens von Birgelen","doi":"10.1007/s12928-024-01073-7","DOIUrl":"https://doi.org/10.1007/s12928-024-01073-7","url":null,"abstract":"Patients undergoing percutaneous coronary intervention (PCI) may experience bleeding events. Bleeding risk is increased in patients with comorbid peripheral arterial disease (PADs). To evaluate whether PCI patients with PADs have worse outcome after bleeding, we assessed pooled patient-level data of 5,989 randomized all-comer trial participants and identified those who had a bleeding (BIO-RESORT:NCT01674803, BIONYX:NCT02508714). Major adverse cardiac events (MACE) and mortality were assessed from bleeding until 3 years after PCI. Of all 313 PCI patients with bleeding events, patients with PADs (n = 34, 10.9%) were older and had more complex lesions than those without PADs (n = 279, 89.1%). In patients with PADs, bleeding occurred more often during the first year after PCI (79.4% vs. 57.3%, p = 0.013). The proportion of major bleeding, and the severity and location of bleeding were similar between both groups. Multivariate analysis found no statistically significant between-group difference in MACE (43.1% vs. 34.7%, p = 0.53; adj.HR:0.86, 95%CI 0.45-1.63, p = 0.64) and mortality (33.5% vs. 22.3%, p = 0.12; adj.HR:1.45, 95%CI 0.73-2.91, p = 0.29). Bleeding occurred significantly more often during the first year after PCI in all-comer patients with concomitant PADs than in those without PADs, while we observed no significant between-group difference in bleeding severity and location, and the risk of adverse events after bleeding.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142853001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Detection and nanagement of stent under-expansion in self-expanding TAVR using a steep right anterior oblique view. 自扩张TAVR中支架扩张不足的检测与处理。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-19 DOI: 10.1007/s12928-024-01078-2

Umihiko Kaneko, Daisuke Hachinohe, Ryo Horita, Ryo Otake, Kazuki Mizutani, Ken Kobayashi

引用次数: 0

Comparison of invasive and non-invasive gradients before and after TAVI and their implications on clinical outcomes. TAVI前后有创和无创梯度的比较及其对临床结果的影响。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-19 DOI: 10.1007/s12928-024-01074-6

Anna Pfenniger, Thorald Stolte, Jakob Johannes Reichl, Gregor Leibundgut, Max Wagener, Christoph Kaiser, Jasper Boeddinghaus, Felix Mahfoud, Thomas Nestelberger

{"title":"Comparison of invasive and non-invasive gradients before and after TAVI and their implications on clinical outcomes.","authors":"Anna Pfenniger, Thorald Stolte, Jakob Johannes Reichl, Gregor Leibundgut, Max Wagener, Christoph Kaiser, Jasper Boeddinghaus, Felix Mahfoud, Thomas Nestelberger","doi":"10.1007/s12928-024-01074-6","DOIUrl":"https://doi.org/10.1007/s12928-024-01074-6","url":null,"abstract":"Transcatheter aortic valve implantation (TAVI) is recommended for treatment of high-risk aortic stenosis patients. While measuring mean transaortic valve gradient (MG) is crucial in evaluating procedural success, echocardiographic measurements often overestimate direct invasive measurements. This study aimed to examine the discordance between echocardiographic and invasive MGs in TAVI patients and assess their prognostic value on long-term outcomes. This prospective registry included consecutive TAVI patients at a tertiary university hospital. Transthoracic or transoesophageal echocardiography was performed pre-TAVI, at discharge, 1 month, 1, and 5 years with invasive MG measurements obtained peri-procedurally. The primary endpoints were 5-year all-cause mortality and major adverse cardiac events. Among 1353 patients from 2011 to 2023, non-invasive MGs exceeded invasive MGs pre- and post-implantation (43 [36, 52] mmHg vs. 40 [30, 50] mmHg, p < 0.001; 9 [6, 12] mmHg vs. 4 [2, 7] mmHg, p < 0.001) Pre-procedural MGs correlated better than post-procedural MGs (r = 0.70, p < 0.001 vs. r = 0.23, p < 0.001), particularly in self-expandable valves and smaller sinus of Valsalva diameter (SOVd) (r = 0.33, p < 0.001; r = 0.46, p < 0.001 vs R = 0.06, p = 0.701). Non-invasive MG remained stable from discharge (9 [6, 12] mmHg) to 5 years (9 [7, 12] mmHg). While structural valve deterioration and patient-prosthesis mismatch showed no impact, extreme invasive MGs (< 3 or > 6 mmHg) predicted worse outcomes (mortality hazard: 1.25 [1.06, 1.88] and 0.85 [0.8, 0.95], respectively), unlike non-invasive measurements. In conclusion, invasive as compared with non-invasive MGs correlated better before than after valve implantation, whereas invasive MGs were always lower than non-invasive MGs. Lower invasive MGs after TAVI appeared to be associated with favourable long-term outcomes.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142853005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Successful transcatheter edge-to-edge repair with PASCAL devices in a patient with large prolapse and deep cleft. 使用 PASCAL 设备成功为一名大脱垂和深裂患者进行经导管边缘到边缘修补术。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-16 DOI: 10.1007/s12928-024-01077-3

Hiroshi Ohara, Mike Saji, Takayuki Yabe, Shintaro Dobashi, Shojiro Hirano, Takanori Ikeda

引用次数: 0

A novel hemostatic method for Impella removal using a shortened Perclose Proglide™ device under proximal balloon occlusion. 在近端球囊闭塞的情况下，使用缩短的 Perclose Proglide™ 装置拔除 Impella 的新型止血方法。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-13 DOI: 10.1007/s12928-024-01072-8

Yumika Tsuji, Masao Takigami, Shunta Taminishi, Makoto Saburi, Yoshinori Tsubakimoto, Jun Shiraishi

引用次数: 0

Comparison of clinical outcomes between direct and indirect transfer in patients with ST-segment elevation myocardial infarction. st段抬高型心肌梗死直接与间接转移治疗的临床效果比较。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-11 DOI: 10.1007/s12928-024-01075-5

Yoshiaki Hai, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Takunori Tsukui, Masashi Hatori, Taku Kasahara, Yusuke Watanabe, Shun Ishibashi, Masaru Seguchi, Hideo Fujita

{"title":"Comparison of clinical outcomes between direct and indirect transfer in patients with ST-segment elevation myocardial infarction.","authors":"Yoshiaki Hai, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Takunori Tsukui, Masashi Hatori, Taku Kasahara, Yusuke Watanabe, Shun Ishibashi, Masaru Seguchi, Hideo Fujita","doi":"10.1007/s12928-024-01075-5","DOIUrl":"https://doi.org/10.1007/s12928-024-01075-5","url":null,"abstract":"Primary percutaneous coronary intervention (PCI) is the cornerstone of treatment for ST-segment elevation myocardial infarction (STEMI). Previous studies suggest that direct transport by ambulance to a primary PCI facility is associated with better clinical outcomes in patients with STEMI. However, those studies included seriously ill patients for whom direct transport is the only option. We included 462 patients with STEMI who were supposed to select either direct transport by ambulance or indirect transport via primary care doctor, and compared the clinical outcomes between the direct transfer group (n = 172) and the indirect transfer group (n = 290). The primary endpoint was major adverse cardiovascular events (MACE), which was defined as the composite of all-cause death, non-fatal myocardial infarction, re-admission for heart failure, and target vessel revascularization. The median follow-up duration was 540 days (86-1266 days). Age was significantly higher in the indirect transfer group [72.0 (64-80) years] than in the direct transfer group [69.5 (58.3-77) years] (p = 0.013). Onset to balloon time was significantly shorter in the direct transport group (p < 0.001). The Kaplan-Meier curves revealed that MACE were similarly observed between the two groups (31.4% vs. 27.2%; p = 0.330). After adjusting for potential confounders, indirect transfer was not associated with MACE (adjusted hazard ratio: 0.740, 95% confidence interval: 0.485-1.128, p = 0.161). In conclusion, indirect transfer was not associated with poor clinical outcomes in patients with STEMI who were supposed to select either direct transport or indirect transport.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impella CP pump failure due to hair involvement in a patient undergoing extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest. 因院外心脏骤停而接受体外心肺复苏的患者因头发受累导致的Impella CP泵衰竭。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-10 DOI: 10.1007/s12928-024-01071-9

Kazuya Nakamura, Shutaro Isokawa, Tasuku Hada, Yu Watanabe, Toru Hifumi, Norio Otani

引用次数: 0

Transcatheter mitral valve replacement in failed surgical annuloplasty ring with Impella support. 经导管二尖瓣置换术在失败的外科环成形术环与Impella支持。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-06 DOI: 10.1007/s12928-024-01068-4

Daisuke Hachinohe, Ryo Horita, Shah Sagar, Ryo Ohtake, Hidemasa Shitan, Kazuki Mizutani

引用次数: 0

Effect of cutting frequency in the jet stream atherectomy system on lumen area acquisition. 射流动脉粥样硬化切除术系统中切割频率对管腔面积获取的影响。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2024-12-05 DOI: 10.1007/s12928-024-01069-3

Naoya Kurata, Osamu Iida, Motoki Yasunaga, Taku Toyoshima, Takafumi Masai, Yoshiharu Higuchi

引用次数: 0